Announced
Completed
Financials
Tags
dermal fillers
collagen solutions
aesthetic dermatology
Pharmaceuticals
United Kingdom
Public
Acquisition
Scheme
Friendly
Single Bidder
Completed
Majority
Synopsis
Huadong Medicine, a Chinese pharmaceutical company, completed the acquisition of Sinclair Pharma, a global aesthetics company, for $222m. “This is a significant and exciting opportunity for Sinclair Pharma, positioning us to expand our global operation that aims to be one of the leaders in aesthetics. We continue our commitment to be partners to physicians and to enriching our portfolio with unique, innovative aesthetics products and procedures,” Chris Spooner, Sinclair Chief Executive Office
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.